- Home
- HSCS vs SXTP Comparison
HSCS vs SXTP Comparison
Compare HSCS & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- SXTP
- Stock Information
- Founded
- HSCS 2007
- SXTP 2010
- Country
- HSCS United States
- SXTP United States
- Employees
- HSCS N/A
- SXTP N/A
- Industry
- HSCS Medical Specialities
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- SXTP Health Care
- Exchange
- HSCS Nasdaq
- SXTP Nasdaq
- Market Cap
- HSCS 2.8M
- SXTP 2.4M
- IPO Year
- HSCS 2022
- SXTP 2023
- Fundamental
- Price
- HSCS $3.17
- SXTP $1.73
- Analyst Decision
- HSCS Strong Buy
- SXTP Hold
- Analyst Count
- HSCS 2
- SXTP 1
- Target Price
- HSCS $13.50
- SXTP N/A
- AVG Volume (30 Days)
- HSCS 16.4K
- SXTP 89.1K
- Earning Date
- HSCS 03-25-2025
- SXTP 03-31-2025
- Dividend Yield
- HSCS N/A
- SXTP N/A
- EPS Growth
- HSCS N/A
- SXTP N/A
- EPS
- HSCS N/A
- SXTP N/A
- Revenue
- HSCS $14,700.00
- SXTP $462,612.00
- Revenue This Year
- HSCS $174.19
- SXTP $150.40
- Revenue Next Year
- HSCS $4,100.00
- SXTP $165.22
- P/E Ratio
- HSCS N/A
- SXTP N/A
- Revenue Growth
- HSCS 151.28
- SXTP 128.99
- 52 Week Low
- HSCS $2.36
- SXTP $1.41
- 52 Week High
- HSCS $13.50
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- HSCS 35.81
- SXTP 33.40
- Support Level
- HSCS $2.62
- SXTP $1.41
- Resistance Level
- HSCS $3.09
- SXTP $3.34
- Average True Range (ATR)
- HSCS 0.32
- SXTP 0.24
- MACD
- HSCS -0.09
- SXTP 0.05
- Stochastic Oscillator
- HSCS 20.55
- SXTP 22.31
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.